NR4A1 and breast cancer: BC subtypes are mainly classified by hormonal receptor status: ER+ are BC with preponderance of tumor cells expressing estrogen receptors, and PR+ with cells expressing progesterone receptors, where HER2 cells carry human epidermal growth factor receptors [1].